MME and Alzheimer disease: Additionally, Aβ could undergo enzymatic degradation via neprilysin, the main soluble Aβ degrading enzyme, the expression of which has been reported as decreased in brains of several murine models of AD and in in vitro models (Tampellini et al., 2011; Grimm et al., 2013).